Scarica l'app Stockscreener
4.2028
2.32%
-0.1072
Trisalus Life Sciences Inc Borsa (TLSI) Ultime notizie
Form 4 TriSalus Life Sciences Inc For: 6 July By Investing.com - Investing.com Canada
TriSalus (TLSI) CFO has shares withheld to cover RSU tax obligations - Stock Titan
TriSalus Life Sciences, Inc. Warrant 2023-04.08.2028 on TriSalus Life Sciences Financial Disclosures & SEC Filings - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages TriSalus Life Scien - The National Law Review
TriSalus Life Sciences (TLSI) Stock Analysis Report | Financials & Insights - Benzinga
TriSalus (TLSI) CEO Mary Szela acquires 3,990 ESPP shares, now holds 1.08M - Stock Titan
TriSalus Life Sciences (TLSI) CCO acquires 561 ESPP shares - Stock Titan
Price to earnings forward of TriSalus Life Sciences, Inc. – NASDAQ:TLSI - TradingView
Form 4 TriSalus Life Sciences Inc For: 29 June By Investing.com - Investing.com Canada
TriSalus Life Sciences (TLSI) CMO awarded RSUs and 120,000-share option grant - Stock Titan
TriSalus (TLSI) CMO discloses common stock and option holdings in Form 3 - Stock Titan
TriSalus Life Sciences, Inc.(NasdaqGM:TLSI) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
TriSalus Life Sciences, Inc.(NasdaqGM: TLSI) dropped from Russell 3000 Value Benchmark - marketscreener.com
TriSalus Life Sciences, Inc.(NasdaqGM: TLSI) dropped from Russell 2500 Value Benchmark - marketscreener.com
TriSalus Life Sciences, Inc.(NasdaqGM:TLSI) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
TriSalus Life Sciences, Inc.(NasdaqGM: TLSI) dropped from Russell 2000 Value Benchmark - marketscreener.com
TriSalus Life Sciences, Inc. Actuals & Estimates (NASDAQ:TLSI) - TradingView
TLSI Forecast — Price Target — Prediction for 2027 - TradingView
Canaccord reiterates TriSalus stock Buy rating after KOL event - Investing.com UK
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc.TLSI - PR Newswire
CCORF Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Canaccord reiterates TriSalus stock Buy rating after KOL event By Investing.com - Investing.com UK
TriSalus Life Sciences (TLSI) Gains 3.23% as Shares Test Resistance at $4.37Ichimoku Kumo Twist - dars.gov.et
TriSalus Life Sciences Inc (TLSIW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TLSI News | TRISALUS LIFE SCIENCES INC (NASDAQ:TLSI) - ChartMill
TriSalus Life Sciences Inc (TLSIW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TriSalus Life Sciences Inc (TLSIW) Institutional Confidence - TradingKey
TriSalus Life Sciences Inc (TLSIW) Valuation: PE, PB & Fair Value Analysis - TradingKey
TriSalus Life Sciences Inc (TLSIW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TriSalus Life Sciences Inc (TLSI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TriSalus Life Sciences Inc (TLSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TriSalus Life Sciences Inc (TLSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TriSalus Life Sciences Inc (TLSI) Institutional Confidence - TradingKey
TriSalus Life Sciences Inc (TLSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TriSalus Life Sciences Inc (TLSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TriSalus Life Sciences Inc (TLSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TriSalus Life Sciences Inc (TLSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
TriSalus Life Sciences Inc (TLSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TriSalus Life Sciences Inc (TLSIW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TriSalus Life Sciences Inc (TLSIW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TriSalus Life Sciences Inc (TLSIW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Richard Marshall Accepts New Role at TriSalus Life Sciences - Medical Product Outsourcing
TriSalus Life Sciences Warrants (TLSIW) Hold Steady Near Support in Quiet TradingAndrews Pitchfork - newsline.com
TLSI Q1 2026 Earnings: EPS Surprise of 118.86% Drives Stock HigherAnalyst Drop Coverage - newsline.com
TriSalus Life Sciences (TLSI) Q1 2026 Earnings: Surprise Profitability as EPS Beats Estimates by 118.86% - newsline.com
TriSalus Life Sciences (TLSI) Gains 2.88% as Stock Approaches Key Resistance LevelWave Extension - newsline.com
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer - Stock Titan
TriSalus Life Sciences Inc. (TLSI) Q1 2026 Earnings: Strong EPS Surprise Driven by Operational ProgressFree Cash Flow Trends - newsline.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TriSalus Life Sciences, Inc. (TLSI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
TLSI INVESTOR ALERT: Holzer & Holzer, LLC Investigation of TriSalus Life Sciences, Inc. - GlobeNewswire
TriSalus Life Sciences, Inc. (TLSI) Investigation: Bronstein, Gew - The National Law Review
TriSalus Life Sciences, Inc. (TLSI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages TriSalus Life Sciences, Inc. (TLSI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2026-06-03 | Bronstein, Gewirtz & Grossman, LLC Encourages TriSalus Life Sciences, Inc. (TLSI) Shareholders to Inquire about Securities Investigation | NDAQ:TLSI | Press Release - Stockhouse
TSLI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating TriSalus Life Sciences, Inc. (TLSI) And Encourages Investors to Connect - ACCESS Newswire
0.32%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):